Dr. Joshua Reicher demystified how radiology and artificial intelligence (AI) intersect in diagnosing and managing pulmonary fibrosis. He explained the fundamentals of CT scans, what radiologists look for in lung images, and how structural changes like reticulation, honeycombing, and ground-glass opacity indicate progression. He discussed the promise of AI tools, like Fibresolve, to support diagnosis and risk assessment—potentially reducing the need for invasive biopsies. The session also included a dynamic Q&A covering radiation safety, contrast use, prognosis tools, and disease pattern interpretation.
Dr. Joshua Reicher is a radiologist and computer science researcher on the clinical faculty at Stanford and the Palo Alto VA. He is co-founder and CEO of Envaria Inc., a company pioneering FDA-authorized AI tools to assist with the diagnosis and prognosis of pulmonary fibrosis. He previously worked in Google’s AI group and is a UCSD and Stanford-trained physician.
Chapters & Timestamps
- Importance of Imaging in Lung Disease – 2:00
- Lung Anatomy and Imaging Markers – 10:00
- How Doctors Interpret CT Scans for ILD – 13:00
- Diagnostic Workflow & Role of UIP Pattern – 18:00
- Imaging for Monitoring, Progression, and Flares – 22:50
- Introduction to AI and Machine Learning Concepts – 26:00
- Fibresolve: AI-Powered CT Scan Analysis– 27:50
- AI Tools for Prognosis and Future Application – 30:00
Disclaimer
This video is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor for medical concerns. No personal recording or redistribution without PF Warriors written permission.
The page was last reviewed on November 1, 2025

